Re: Jarow et al.: Drug and device development for localized prostate cancer: Report of a Food and Drug Administration/American Urological Association public workshop (Urology 2014;83:975-979)

摘要

There was a sense of disappointment that greater consensus was not achieved by the Food and Drug Administration/ American Urological Association workshop. Clinicians, researchers, patients, and industry were looking for direction and instead witnessed a missed opportunity. We would like to highlight some issues.